Melanocortin 5 receptor activates ERK1/2 through a PI3K-regulated signaling mechanism

Molecular and Cellular Endocrinology

Volumn 303, Issue 1-2, 2009, Pages 74-81

  Rodrigues, Adriana R ^a,b   Pignatelli, Duarte ^a,c   Almeida, Henrique ^a,b   Gouveia, Alexandra M ^a,b  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c HOSPITAL DE SÃO JOÃO   (Portugal)

Author keywords

MSH; Akt PKB; ERK1 2; GPCR; Melanocortin 5 receptor; PI3K

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; G PROTEIN COUPLED RECEPTOR; GREEN FLUORESCENT PROTEIN; MELANOCORTIN 5 RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B INHIBITOR; PROTEIN KINASE C; PROTEIN MC5R; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; WORTMANNIN;

ARTICLE; CELL STIMULATION; CELL STRAIN HEK293; ENZYME ACTIVATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; CELL LINE; CYCLIC AMP; HUMANS; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RECEPTORS, MELANOCORTIN; SIGNAL TRANSDUCTION;

EID: 62949102680     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2009.01.014     Document Type: Article

References (30)

1. Bednarek M.A., MacNeil T., Tang R., Fong T.M., Cabello M.A., Maroto M., and Teran A. Potent and selective agonists of alpha-melanotropin (alphaMSH) action at human melanocortin receptor 5; linear analogs of alpha-melanotropin. Peptides 28 5 (2007) 1020-1028
2. Buggy J.J. Binding of alpha-melanocyte-stimulating hormone to its G-protein-coupled receptor on B-lymphocytes activates the Jak/STAT pathway. Biochem. J. 331 (1998) 211-216
3. Catania A., Gatti S., Colombo G., and Lipton J.M. Targeting melanocortin receptors as a novel strategy to control inflammation. Pharmacol. Rev. 56 1 (2004) 1-29
4. Chai B., Li J.Y., Zhang W., Ammori J.B., and Mulholland M.W. Melanocortin-3 receptor activates MAP kinase via PI3 kinase. Regul. Pept. 139 1-3 (2007) 115-121
5. Chen W., Kelly M.A., Opitz-Araya X., Thomas R.E., Low M.J., and Cone R.D. Exocrine gland dysfunction in MC5-R-deficient mice: evidence for coordinated regulation of exocrine gland function by melanocortin peptides. Cell 91 6 (1997) 789-798
6. Cho K.J., Shim J.H., Cho M.C., Choe Y.K., Hong J.T., Moon D.C., Kim J.W., and Yoon D.Y. Signaling pathways implicated in alpha-melanocyte stimulating hormone-induced lipolysis in 3T3-L1 adipocytes. J. Cell Biochem. 96 4 (2005) 869-878
7. Daniels D., Patten C.S., Roth J.D., Yee D.K., and Fluharty S.J. Melanocortin receptor signaling through mitogen-activated protein kinase in vitro and in rat hypothalamus. Brain Res. 986 1-2 (2003) 1-11
8. Davies S.P., Reddy H., Caivano M., and Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351 Pt 1 (2000) 95-105
9. Ferreira J.G., Cruz C., Vinson G.P., and Pignatelli D. ACTH modulates ERK phosphorylation in the adrenal gland in a time-dependent manner. Endocr. Res. 30 4 (2004) 661-666
10. Gao Z., Chen T., Weber M.J., and Linden J. A2B adenosine and P2Y2 receptors stimulate mitogen-activated protein kinase in human embryonic kidney-293 cells. Cross-talk between cyclic AMP and protein kinase C pathways. J. Biol. Chem. 274 9 (1999) 5972-5980
11. Getting S.J. Targeting melanocortin receptors as potential novel therapeutics. Pharmacol. Ther. 111 (2006) 1-15
12. Green C.J., Göransson O., Kular G.S., Leslie N.R., Gray A., Alessi D.R., Sakamoto K., and Hundal H.S. Use of Akti and a drug-resistant mutant validates a critical role for PKB/Akt in the insulin-dependent regulation of glucose and system A amino acid uptake. J. Biol. Chem. 283 41 (2008) 27653-27667
13. Griffon N., Mignon V., Facchinetti P., Diaz J., Schwartz J.C., and Sokoloff P. Molecular cloning and characterization of the rat fifth melanocortin receptor. Biochem. Biophys. Res. Commun. 200 2 (1994) 1007-1014
14. Hoogduijn M.J., McGurk S., Smit N.P., Nibbering P.H., Ancans J., van der Laarse A., and Thody A.J. Ligand-dependent activation of the melanocortin 5 receptor: cAMP production and ryanodine receptor-dependent elevations of [Ca(2+)](I). Biochem. Biophys. Res. Commun. 290 2 (2002) 844-850
15. Janes M.E., Chu K.M., Clark A.J., and King P.J. Mechanisms of adrenocorticotropin-induced activation of extracellularly regulated kinase 1/2 mitogen-activated protein kinase in the human H295R adrenal cell line. Endocrinology 149 4 (2008) 1898-1905
16. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
17. Mandrika I., Petrovska R., and Wikberg J. Melanocortin receptors form constitutive homo- and heterodimers. Biochem. Biophys. Res. Commun. 326 2 (2005) 349-354
18. Millington G.W. Proopiomelanocortin (POMC): the cutaneous roles of its melanocortin products and receptors. Clin. Exp. Dermatol. 31 3 (2006) 407-412
19. Mountjoy K.G., Kong P.L., Taylor J.A., Willard D.H., and Wilkison W.O. Melanocortin receptor-mediated mobilization of intracellular free calcium in HEK293 cells. Physiol. Genomics 5 1 (2001) 11-19
20. Murphy L.O., and Blenis J. MAPK signal specificity: the right place at the right time. Trends Biochem. Sci. 31 5 (2006) 268-275
21. New D.C., and Wong Y.H. Molecular mechanisms mediating the G protein-coupled receptor regulation of cell cycle progression. J. Mol. Signal 2 (2007) 2
22. Nickolls S.A., and Maki R.A. Dimerization of the melanocortin 4 receptor: a study using bioluminescence resonance energy transfer. Peptides 27 (2006) 380-387
23. Park H.J., Kim H.J., Lee J.Y., Cho B.K., Gallo R.L., and Cho D.H. Adrenocorticotropin hormone stimulates interleukin-18 expression in human HaCaT keratinocytes. J. Invest. Dermatol. 127 5 (2007) 1210-1216
24. Pignatelli D., Maia M., Castro A.R., da Conceição Magalhães M., Vivier J., and Defaye G. Chronic stress effects on the rat adrenal cortex. Endocr. Res. 26 (2000) 537-544
25. Sánchez-Laorden B.L., Sánchez-Más J., Martínez-Alonso E., Martínez-Menárguez J.A., García-Borrón J.C., and Jiménez-Cervantes C. Dimerization of the human melanocortin 1 receptor: functional consequences and dominant-negative effects. J. Invest. Dermatol. 126 1 (2006) 172-181
26. Schwindinger W.F., and Robishaw J.D. Heterotrimeric G-protein βγ-dimers in growth and differentiation. Oncogene 20 (2001) 1653-1660
27. Sun Y., McGarrigle D., and Huang X.-Y. When a G protein-coupled receptor does not couple to a G protein. Mol. BioSyst. 3 (2007) 849-854
28. Vongs A., Lynn N.M., and Rosenblum C.I. Activation of MAP kinase by MC4-R through PI3 kinase. Regul. Pept. 120 1-3 (2004) 113-118
29. Zanna P.T., Sánchez-Laorden B.L., Pérez-Oliva A.B., Turpín M.C., Herraiz C., Jiménez-Cervantes C., and García-Borrón J.C. Mechanism of dimerization of the human melanocortin 1 receptor. Biochem. Biophys. Res. Commun. 368 2 (2008) 211-216
30. Zhang L., Li W.H., Anthonavage M., and Eisinger M. Melanocortin-5 receptor: a marker of human sebocyte differentiation. Peptides 27 2 (2006) 413-420